Another HumKI having the amimopyrimidine moiety that has been evaluated for its antimicrobial activity against S. aureus [22] is Ceritinib (compound 7; Table 1), a tyrosine kinase inhibitor used in cancer treatment to inhibit anaplastic lymphoma kinase (ALK). The gene discussed is ALK; the disease is cancer.